Skip to content
6-K

Foreign Interim / Material

SOPHiA GENETICS SA SOPH

0001840706-24-000123

← back to feed
Filed
Aug 6, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Current Liabilities 2024 · Jun 30, 2024 $28.61M
Current Liabilities 2023 · Dec 31, 2023 $35.62M
Total Liabilities 2024 · Jun 30, 2024 $59.65M
Total Liabilities 2023 · Dec 31, 2023 $54.71M
Current Assets 2024 · Jun 30, 2024 $125.75M
Current Assets 2023 · Dec 31, 2023 $148.05M
Total Assets 2024 · Jun 30, 2024 $181.1M
Total Assets 2023 · Dec 31, 2023 $206.16M
Shares Diluted 2023 · Jun 30, 2023 64.5M sh
Shares Diluted 2023 · Jun 30, 2023 64.37M sh
Operating Cash Flow 2023 · Jun 30, 2023 −$25.11M
Cash And Equivalents 2023 · Jun 30, 2023 $148.55M
Cash And Equivalents 2022 · Dec 31, 2022 $161.31M
Stockholders Equity 2023 · Jun 30, 2023 $171.7M
Stockholders Equity 2023 · Mar 31, 2023 $184.91M
Stockholders Equity 2022 · Dec 31, 2022 $200.13M
Eps Diluted 2023 · Jun 30, 2023 −$0.33
Eps Diluted 2023 · Jun 30, 2023 −$0.64
Eps Basic 2023 · Jun 30, 2023 −$0.33
Eps Basic 2023 · Jun 30, 2023 −$0.64
Rd Expense 2023 · Jun 30, 2023 $8.89M
Rd Expense 2023 · Jun 30, 2023 $18.23M
Net Income 2023 · Jun 30, 2023 −$21.4M
Net Income 2023 · Jun 30, 2023 −$41.1M
Operating Income 2023 · Jun 30, 2023 −$20.05M
Operating Income 2023 · Jun 30, 2023 −$39.33M
Gross Profit 2023 · Jun 30, 2023 $10.05M
Gross Profit 2023 · Jun 30, 2023 $19.74M
Cost Of Revenue 2023 · Jun 30, 2023 $5.01M
Cost Of Revenue 2023 · Jun 30, 2023 $9.28M